Effect of zinc tablets in the prevention of acute peripheral neuropathy in cancer patients treated with taxanes

Phase 3

Recruiting

• Conditions: Drug-induced polyneuropathy.; Drug-induced polyneuropathy; G62.0

• Registration Number: IRCT20200422047166N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Cancer confirmed by biopsy and candidate for chemotherapy containing taxan
Be able to give informed consent.
The patient's performance status should be such that he or she can describe the condition.

Exclusion Criteria

They have diabetes, neurological disorders or neuropathy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of neuropathy. Timepoint: Every 3 weeks for 3 months. Method of measurement: Criteria for side effects table.;Acute neuropathy. Timepoint: Every 3 weeks for 3 months. Method of measurement: Examination.